From Financial Modeling Prep: 2025-04-28 07:00:00

The consensus price target for NOV Inc. (NYSE:NOV) has increased, showing optimism among analysts, but Goldman Sachs sets a lower target due to anticipated challenges. NOV expects a 1-3% revenue decline in the upcoming quarter but projects a higher bottom line due to cost reductions, with adjusted EBITDA estimated between $235 million and $265 million. The company’s stock has declined by 23% over the past six months, reflecting various challenges.



Read more at Financial Modeling Prep:: NOV Inc. (NYSE:NOV) Faces Mixed Financial Outlook …